cinitapride
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2010 (NCT01355276)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Serotonin 4 (5-HT4) receptorAGONIST
HTR4 agonist
Chemistry & pharmacology
Loading structure…
SMILES
CCOc1cc(N)c([N+](=O)[O-])cc1C(=O)NC1CCN(CC2CC=CCC2)CC1- Mol. weight
- 402.5 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2104523 ↗
Also known as
- blaston
- cidine
- cinitapride
- cinitapride
- cinitapride
- cinitapride
- cinitapride
- cinitapride
- cinitapride
- cinitapride tartrate
- cinitapride tartrate
- paxapride
- paxapride
- paxapride
- paxapride
- paxapride
- rogastril
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01355276 | Phase 3 | Oct 1, 2010 | Eisai, Jiao Tong University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eisai | For profit | 1 | 1 | 1 | 2010 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2010 |
2 organizations
Page 1 / 1